EDWARDS LIFESCIENCES CORP
10-Q, EX-27.5, 2000-08-11
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: EDWARDS LIFESCIENCES CORP, 10-Q, EX-10.23, 2000-08-11
Next: INTECHNOLOGIES INC, NT 10-Q, 2000-08-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM EDWARDS
LIFESCIENCES CONSOLIDATED CONDENSED BALANCE SHEET AT JUNE 30, 2000,CONSOLIDATED
CONDENSED STATEMENT OF INCOME FOR THE THREE MONTHS ENDED JUNE 30, 2000, AND
CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30,
2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<CIK> 0001099800
<NAME> EDWARDS LIFESCIENCES CORPORATION
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                               2
<SECURITIES>                                         0
<RECEIVABLES>                                      162
<ALLOWANCES>                                         0
<INVENTORY>                                         95
<CURRENT-ASSETS>                                   295
<PP&E>                                             178
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   1,123
<CURRENT-LIABILITIES>                              331
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            58
<OTHER-SE>                                         353
<TOTAL-LIABILITY-AND-EQUITY>                     1,123
<SALES>                                            205
<TOTAL-REVENUES>                                   205
<CGS>                                              115
<TOTAL-COSTS>                                      509
<OTHER-EXPENSES>                                     1
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   6
<INCOME-PRETAX>                                  (311)
<INCOME-TAX>                                       (2)
<INCOME-CONTINUING>                              (309)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (309)
<EPS-BASIC>                                     (5.31)
<EPS-DILUTED>                                   (5.31)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission